v3.26.1
Summary of Significant Accounting Policies - Schedule of Net Loss Per Common Share (Details) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Summary of Significant Accounting Policies - Schedule of Net Loss Per Common Share (Details) [Line Items]    
Net loss (in Dollars) $ (2,600,262) $ (3,959,440)
Weighted average shares outstanding – basic 47,902,512 16,312,468
Weighted average shares outstanding diluted 47,902,512 16,312,468
Net loss per share – basic (in Dollars per share) $ (0.05) $ (0.24)
Net loss per share diluted (in Dollars per share) $ (0.05) $ (0.24)
Public Warrants [Member]    
Summary of Significant Accounting Policies - Schedule of Net Loss Per Common Share (Details) [Line Items]    
Anti-dilutive shares outstanding [1] 9,877,432 11,500,000
Private Warrants [Member]    
Summary of Significant Accounting Policies - Schedule of Net Loss Per Common Share (Details) [Line Items]    
Anti-dilutive shares outstanding [1] 557,000 557,000
Bridge Warrants [Member]    
Summary of Significant Accounting Policies - Schedule of Net Loss Per Common Share (Details) [Line Items]    
Anti-dilutive shares outstanding [1] 173,913 173,913
Extension Warrants [Member]    
Summary of Significant Accounting Policies - Schedule of Net Loss Per Common Share (Details) [Line Items]    
Anti-dilutive shares outstanding [1] 26,086 26,086
September 2024 Warrants [Member]    
Summary of Significant Accounting Policies - Schedule of Net Loss Per Common Share (Details) [Line Items]    
Anti-dilutive shares outstanding [1] 740,741 740,741
Quantum Note [Member]    
Summary of Significant Accounting Policies - Schedule of Net Loss Per Common Share (Details) [Line Items]    
Anti-dilutive shares outstanding [1],[2] 206,928 1,862,466
Exchange Note [Member]    
Summary of Significant Accounting Policies - Schedule of Net Loss Per Common Share (Details) [Line Items]    
Anti-dilutive shares outstanding [1],[3] 0 827,330
September 2024 Convertible Note [Member]    
Summary of Significant Accounting Policies - Schedule of Net Loss Per Common Share (Details) [Line Items]    
Anti-dilutive shares outstanding [3] 0 [1] 1,258,733
Series A Preferred Stock [Member]    
Summary of Significant Accounting Policies - Schedule of Net Loss Per Common Share (Details) [Line Items]    
Anti-dilutive shares outstanding [1],[4] 210,850 3,079,000
Series B Preferred Stock [Member]    
Summary of Significant Accounting Policies - Schedule of Net Loss Per Common Share (Details) [Line Items]    
Anti-dilutive shares outstanding [5] 1,300,000
Share-Based Payment Arrangement, Option [Member]    
Summary of Significant Accounting Policies - Schedule of Net Loss Per Common Share (Details) [Line Items]    
Anti-dilutive shares outstanding [1] 803,646 803,646
Common Stock Issuance Obligation [Member]    
Summary of Significant Accounting Policies - Schedule of Net Loss Per Common Share (Details) [Line Items]    
Anti-dilutive shares outstanding [1] 51,192 51,192
March 2025 Convertible Note [Member]    
Summary of Significant Accounting Policies - Schedule of Net Loss Per Common Share (Details) [Line Items]    
Anti-dilutive shares outstanding   7,543
Common Stock Warrants [Member]    
Summary of Significant Accounting Policies - Schedule of Net Loss Per Common Share (Details) [Line Items]    
Anti-dilutive shares outstanding [1] 19,672,130 0
[1] The Company’s dilutive shares have not been included in the computation of diluted net loss per share for the three months ended March 31, 2026, and 2025, as the result would be anti-dilutive.
[2] Includes the interest amount thereon and assumes the floor conversion price of $2.00, was partially converted during the year in 2025.
[3] Fully converted during the year 2025.
[4] Assumes the maximum conversion thereon at the floor conversion price of $2.00, partially converted during the year 2025.
[5] Assumes the maximum conversion thereon at the floor conversion price of $0.65.